Close Menu

NEW YORK – In more than a dozen recently published comparisons of commercial molecular diagnostic SARS-Cov-2 tests, researchers have generally found them to have similar performance. Since many tests are proving to be highly accurate, factors such as location of testing, time to results, and workflow may ultimately be more pivotal for labs needing to bring on testing. 

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.